跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 82 条关于
“Hutchison MediPharma”
全部
82
临床试验
12
药物
23
机构
27
资讯
20
去年
Hutchison MediPharma's Sovleplenib Demonstrates Efficacy in Autoimmune Disorders
去年
Advancements in HER2-Positive Gastric Cancer Treatment Landscape
12个月前
Novartis Ianalumab Combination Shows 45% Improvement in ITP Disease Control in Phase III Trial
去年
Neuroendocrine Tumor Pipeline Shows Strong Growth with 75+ Therapies in Development
4年前
Fruquintinib Granted US FDA Fast Track Designation for Metastatic Colorectal Cancer Treatment
去年
Abbott Partners with Epic to Integrate FreeStyle Libre CGM Data into Electronic Health Records
去年
Madrigal's Resmetirom Shows Promise in NASH Treatment Where Others Have Failed
去年
HUTCHMED Reports 65% Growth in Oncology Products Revenue, Achieves Profitability in 2024
6个月前
Sentynl Therapeutics Licenses Progerinin for Hutchinson-Gilford Progeria Syndrome Treatment
去年
Fred Hutchinson Biostatistician Pioneers Novel Approaches in Cancer Clinical Trial Design
第 1 页,共 2 页
上一页
下一页